Connect with us

Health

New data shows effect South African virus variant has on vaccine efficacy – CCTV

A coronavirus variant first identified in South Africa is weakening the ability of two COVID-19 vaccines to protect against the disease, according to clinical trial…

Published

on

post featured image

A coronavirus variant first identified in South Africa is weakening the ability of two COVID-19 vaccines to protect against the disease, according to clinical trial data, scientists said.
Initial data from Novavax Inc and Johnson & Johnson showed their vaccines significantly less effective at preventing COVID-19 in trial participants in South Africa.
The scientists said this development highlighted the need to vaccinate as many people as quickly as possible.
Mid-stage trial results released by Novavax…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending